Tyson Foods (NYSE: TSN) is projected to report its Q4 earnings at $0.69 per share on revenue of $8.89 billion.

AmeriGas Partners LP (NYSE: APU) is estimated to post a Q4 loss at $0.48 per share on revenue of $585.42 million.

Brocade Communications Systems (NASDAQ:

Below are the top large-cap health care plans stocks on the NYSE and the NASDAQ in terms of operating margin.

The trailing-twelve-month operating margin at Cigna (NYSE: CI) is 10.50%.

Below are the top small-cap textile industrial stocks on the NYSE and the NASDAQ in terms of revenue estimate for the current year.

Albany International (NYSE: AIN) is likely to post revenue of $759.80 million in the year ending December, 2013.

Below are the top small-cap diversified utilities stocks on the NYSE and the NASDAQ in terms of earnings per share.

The trailing-twelve-month earnings per share at Northwestern (NYSE: NWE) is $3.33.

Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of PEG ratio.

Valeant Pharmaceuticals International (NYSE: VRX) has a PEG ratio of 1.09. Valeant's trailing-twelve-month revenue is $4.69 billion.

Elan Corporation plc (NYSE: ELN) has a PEG ratio of 1.84.

Some of the stocks that may grab investor focus today are:

Wall Street expects Tyson Foods (NYSE: TSN) to report its Q4 earnings at $0.69 per share on revenue of $8.89 billion.

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday November 15 through Sunday November 17, 2013:

Jos A Bank Teminates $48.00/Share Offer for Men's Wearhouse, Eminence Capital Requests Talks

The Offer Termination:
Jos. A.

--

Alnylam
Pharmaceuticals (NASDAQ: ALNY) announced today that it has presented new pre-clinical data
from two RNAi therapeutic programs for cardiovascular disease,
including: ALN-PCSsc, an RNAi therapeutic targeting PCSK9 for the
treatment of hypercholesterolemia; and ALN-ANG, an RNAi therapeutic
targeti

The focus is on retail as the as the crucial holiday shopping season is set to get underway.

PrimeSense responded in an email to Benzinga Sunday, to a report by Israeli newspaper Calcalist. that it was being acquired by Apple for $345M:

"PrimeSense is the leading 3D technology in the market.